Trichuris suis soluble products induce Rab7b expression and limit TLR4 responses in human dendritic cells

Area of Science:

• Immunology
• Parasitology
• Molecular Biology

Background:

• Inflammatory immune disorders like inflammatory bowel disease and multiple sclerosis pose significant health challenges.
• The intestinal whipworm, Trichuris suis, is being investigated for its potential to mitigate inflammation in these conditions.
• The precise mechanisms by which T. suis influences the host immune system remain largely unknown.

Purpose of the Study:

• To investigate the effects of Trichuris suis soluble products (SPs) on Toll-like receptor-4 (TLR4)-stimulated human dendritic cells (DCs).
• To elucidate the molecular pathways involved in the immunomodulatory effects of T. suis SPs.

Main Methods:

• Human dendritic cells (DCs) were stimulated with lipopolysaccharide (LPS) and treated with T. suis soluble products (SPs).
• Gene expression profiling was performed using Illumina bead chip arrays.
• Quantitative real-time PCR and protein level analysis were used to validate key gene expressions.
• Flow cytometry was employed to assess surface TLR4 expression.

Main Results:

• T. suis SPs downregulated both myeloid differentiation primary response gene 88 (MyD88)-dependent and TIR-domain-containing adaptor-inducing interferon-β (TRIF)-dependent signaling pathways triggered by TLR4.
• Treatment with T. suis SPs led to the induction of Rab7b, a negative regulator of TLR4 signaling.
• A reduced surface expression of TLR4 on dendritic cells was observed following T. suis SPs treatment.

Conclusions:

• Trichuris suis soluble products exert anti-inflammatory effects by suppressing TLR4 signaling pathways in human dendritic cells.
• The mechanism involves the downregulation of TLR4 surface expression and interference with downstream signaling cascades.
• These findings provide crucial insights into the immunomodulatory potential of T. suis for treating inflammatory diseases.